Two mycoplasmas recovered from human urogenital tracts were similar in their biochemical and serological properties. These organisms possessed a unique terminal structure that appeared to be associated with attachment to tissue cells and erythrocytes. The organisms fermented glucose but did not hydrolyze urea or arginine. Growth occurred at 30 to 37°C. Cholesterol was required for growth. Unlike most other mycoplasmas, both strains were susceptible to thallium acetate. These two organisms were serologically distinct from other Mycoplasma species and from a group of unclassified serotypes of mycoplasmas. On the basis of these findings and other morphological, biological, and serological properties of the microorganisms, we propose that mycoplasmas with these characteristics belong to a new species, Mycoplasma genitalium. Strain G-37 (= ATCC 33530) is the type strain.
It is thought that the mycoplasma flora of humans consists of 11 distinct microorganisms, including nine Mycoplasma species, Acholeplasma laidlawii, and Ureaplasma urealyticrrm (6). At least six of these microorganisms are known to occur in human urogenital tracts. Mycoplasma hominis and U . urealyticum are found most frequently in urogenital tracts, and each of these species has been implicated as a cause of some urogenital tract disease (26, 27) . Four other mycoplasmas, Mycoplasma fermentans, Mycoplasma primatum, Mycoplasma salivarium, and Mycoplasma pneumoniae, are found only rarely in urogenital specimens, and there is no clear evidence that these species are associated with urogenital disease.
Although a wide variety of urogenital and reproductive disorders in humans have been associated with M . hominis or U . urealyticum, it has been difficult to establish a direct etiological role for these microorganisms because they often occur as frequently in patients without disease as in patients with disease (26, 27 ). In addition, recent studies on nongonococcal urethritis (NGU) in humans have indicated that although both U . urealyticum and chlamydiae are involved in this disease, in approximately 20% of the NGU cases examined no bacterial or mycoplasmal agent could be recovered on the usual laboratory media (4). Nevertheless, a proportion of patients with no apparent agent present respond to tetracycline therapy.
These and other observations suggest that other more fastidious mycoplasmas or other tetracycline-susceptible microorganisms or both might be involved in NGU and perhaps other clinical conditions. The availability of a new mycoplasma medium developed recently to cultivate tick-derived mycoplasmas (spiroplasmas) (31) was found to enhance isolation of M . pneumoniae from human throat washings and to support growth of several other fastidious mycoplasmas (29). This medium (SP-4 medium) was used to examine a number of specimens from patients with NGU. A mycoplasma unrelated to other previously classified Mycoplasma species was isolated (27, 30) . In this report, we present the characteristics of this microorganism. On the basis of distinct biological and serological properties, we propose that this microorganism be given taxonomic status as a new Mycoplasma species.
tion procedures was SP-4 medium (31) . This medium was prepared as follows: 3.5 g of mycoplasma broth base (BBL Microbiology Systems, Cockeysville, Md.), 10 g of tryptone (Difco Laboratories, Detroit, Mich.), 5.3 g of peptone (Difco), and 5 g of glucose were placed in a 2-liter flask, and 615 ml of deionized water was added. As soon as the base medium was in solution, it was adjusted (with 1 N NaOH) to pH 7.6 to 7.8, and the preparation was then sterilized at 121°C for 15 to 20 min. After cooling, the base medium was supplemented with the following sterile components: 50 ml of tissue culture supplement CMRL 1066 (lox, with glutamine; GIBCO Laboratories, Grand Island, N.Y.), 35 ml of a fresh 25% yeast extract solution (Flow Laboratories, Inc., Rockville, Md.), 100 ml of a 2% TC Yeastolate solution (Difco), 170 ml of fetal bovine serum (FBS) heated at 56°C for 1 h (Sterile Systems, Logan, Utah), 10 ml of penicillin (100,000 U/ ml), and 20 ml of a 0.1% phenol red solution. The final pH was 7.4 to 7.5. Solid medium was prepared by adding 0.8% Noble agar (Difco) or 0.6% agarose (Seakem ME; RMC Corp., Rockland, Maine) to the base medium before sterilization.
The components of tissue culture supplement CMRL 1066 sometimes interfered with the biochemical tests. For this reason, a culture medium containing 70% mycoplasma broth base (BBL), 10% fresh yeast extract (25% solution; Flow), and either 20% FBS (Sterile Systems) or 20% horse serum (Flow) was used. Medium containing FBS was supplemented with 0.5% glucose, 500 U of penicillin per ml, and 0.002% phenol red and was solidified by adding 0.6% agarose (Seakem ME).
Strains G-37T and M-30 were usually grown in 10 ml of SP-4 medium in T-25 tissue culture flasks that were incubated horizontally at 37°C. As the pH moved to the acid range (yellow) during growth, a layer of cells adherent to the surface of each plastic flask became apparent. The medium was pipetted off, and 2 ml of fresh SP-4 medium was added to the flask. The cells were then scraped off the surface with a sterile, bent glass rod which had a rubber tip. The resulting cell suspension was used to inoculate agar media or to carry out other procedures in the characterization process. Agar cultures were usually incubated anaerobically in a GasPak container (BBL) at 37°C.
Strains G-37T and M-30 were purified by a threefold filtration-cloning procedure (23). This involved passing a cell suspension scraped from a T-25 flask through a membrane filter (Millex; pore size, 220 nm; Millipore Corp., Bedford, Mass.), inoculating agarose plates with undiluted filtrate or appropriate 10-fold dilutions (usually lo-' and lop2) in SP-4 broth medium, selecting single colonies from the resulting growth, and inoculating each of these colonies into 5 ml of SP-4 broth medium; this procedure was repeated two more times.
SP-4 broth medium prepared as described above but devoid of penicillin or any other antibiotic was used to detect a possible change of strain G-37T to a bacterial form. At least five passages in antibiotic-free medium were performed in T-25 flasks, and the cell suspensions were inoculated onto blood agar plates and Gram stained at each passage. The agar plates were incubated aerobically at 37°C and examined for bacterial colonies.
We examined the effects of different concentrations
(1:2,000 to 15,000, equivalent to 0.05 to 0.02% [wt/vol]) of thallium acetate and polymyxin B (500 U/ml) on the growth of strain G-37T in SP-4 broth medium. The compounds were incorporated into the SP-4 medium, which was distributed to a series of screw-capped vials (1.8 ml in each). A 0.2-ml volume of a suspension of strain G-37T grown in a T-25 flask was added to the first vial in the thallium series, the polymyxin series, and a control SP-4 medium series.
Tenfold dilutions of the mycoplasma suspension were then made, up to a lo-' dilution. The growth of strain G-37T in each series of vials was assessed by noting pH changes (red to yellow) in the SP-4 broth medium; the vials were incubated at 37°C for 28 days.
Morphology. The morphologies of the two mycoplasma strains were examined by conventional darkfield techniques and by electron microscopy, using both negative staining procedures and sectioning of organism pellets. For negative staining, organisms were removed from the surface of a T-25 flask with a small amount of SP-4 broth medium and centrifuged, and the resulting pellet was suspended in 1% ammonium acetate. The organisms were then stained with 2% ammonium molybdate, as described previously (9). Some suspensions were initially fixed briefly in 1% glutaraldehyde or by using glutaraldehyde vapor. For sectioning, organism pellets prepared from growth in a T-25 flask or strain G-37-infected Vero cell cultures were fixed for 5 h at room temperature with 3% glutaraldehyde in 0.1 M phosphate buffer (pH 7.0). After two washes in buffer, secondary fixation was carried out in 1% osmium tetroxide for 5 h at room temperature or overnight at 4°C. After one or two washes in Verona1 acetate buffer (18) without CaCI,, the material was exposed overnight at room temperature to 0.5% uranyl acetate in the same buffer and subsequently enrobed in 3% Noble agar. Cubes of agar were dehydrated and embedded in Spurr medium by standard methods (9). Silver sections were cut with an LKB Ultratome 111 and stained with Reynold lead citrate, as previously described (9). All electron microscopy and photography were performed by using a Hitachi model HU 11-C electron microscope operated at 75 kV.
Filtration studies. A suspension of strain G-37T cells obtained from growth in SP-4 medium in a T-25 flask for 5 days was examined for passage through a series of membrane filters with graded pore diameters (average pore diameters, 450, 300, 220, and 100 nm). An unfiltered suspension (0.2 ml) was used as a control, and this suspension and each filtrate were diluted in 10-fold steps in 1-dram (3.75-ml) vials containing 1.8 ml of SP-4 broth medium. The vials were incubated at 37"C, and the endpoint of each titration was considered to be the highest dilution at which the medium changed color to yellow and there was granular turbidity (typical of the growth of strain G-37T). The highest dilution showing a color change contained 1 colorchanging unit (CCU) of mycoplasmas.
Tests for biological and biochemical properties. The procedures used to determine glucose fermentation, arginine hydrolysis, urea hydrolysis, phosphatase activity, tetrazolium reduction, serum liquefaction, and film and spot reactions have been described previously (2, 5). Most of these procedures and the digitonin test (13) were performed with broth or agarose media containing FBS. Hemadsorption of guinea pig erythro-On: Fri, 22 Mar 2019 18:31:02 VOL. 33, 1983 MYCOPLASMA GENITALIUM SP. NOV. 389 cytes to colonies of strains G-37T and M-30 on agarose medium or to growth adherent to T-25 plastic flasks was assessed by techniques described previously (19). We also examined the ability of human type 0 erythrocytes before and after treatment with purified neuraminidase (20) to absorb to strain G-37T colonies on agar. Sterol requirement. The sterol requirement of strain G-37T was determined by a technique that was modified slightly from the recommended direct broth culture method (21), as described recently (32) . Briefly, the modified method involved growing strain G-37T in serum-free base medium to which different amounts of cholesterol or FBS were added and comparing the growth (recorded as number of CCU per milliliter) with the growth in serum-free medium.
Serological tests. Hyperimmune antisera to the mycoplasmas listed in Table 1 were prepared. Some of these antisera were antisera prepared as part of the National Institutes of Health mycoplasma reference reagent program (11). The methods used to prepare antisera to the remaining mycoplasmas have been described elsewhere (28). Disk growth inhibition tests (8) were performed with suspensions of strain G-37T cells that had been grown at 37°C on the surfaces of T-25 plastic flasks containing SP-4 broth medium. The suspensions were usually diluted 150 or 1:lOO and then plated onto SP-4 medium or FBS medium containing agarose. When the media appeared to be dry, paper disks saturated with 0.25 ml of undiluted mycoplasma antiserum were placed onto the surfaces, and the plates were incubated anaerobically at 37°C in the Table  1 . Deoxyribonucleic acid. The guanine-plus-cytosine content of purified deoxyribonucleic acid of strain G-37T was determined by buoyant density, which was measured by equilibration centrifugation in a CsCl gradient, using techniques described previously (17). Purified deoxyribonucleic acid from Spiroplasmu citri (guanine-plus-cytosine content, 26 mol%) was used as a reference in this procedure (17).
Tissue culture studies. Attachment of strains G-37T and M-30 to tissue cells was examined by using Vero monkey kidney cells (received from M. F. Barile, Food and Drug Administration, Bethesda, Md.). Portions (0.1 ml) of a 5-day culture of each mycoplasma strain in SP-4 medium were inoculated into 35-mm plastic dishes containing 1-day-old monolayers of Vero cells on glass cover slips covered by Eagle minimum essential medium. After incubation at 37°C for 5 to 7 days, the monolayers were examined by optical microscopy for cytopathic changes. In addition, infected tissue cells on cover slips were fixed in 3% glutaraldehyde for 5 to 18 h at room temperature. The cells were then scraped off the cover slips, centrifuged at 3,000 X g for 5 min, washed in phosphate buffer, and secondarily fixed in 1% osmium tetroxide; the cell pellets were then washed, stained, embedded, sectioned, and examined by electron microscopy, using the techniques described above.
RESULTS
The following description covers the properties of both strain G-37= and strain M-30, except where noted otherwise.
Morphology and ultrastructure. Dark-field microscopy of cultures showed small, discrete, apparently nonmotile, coccoid bodies; no details of these bodies could be resolved. Gram staining revealed small coccoid to irregular gram-negative units. Electron microscopy of either negatively stained (Fig. 1A) or sectioned ( Fig. 1B and  C) material showed that the mycoplasma cells were predominantly flask shaped, although stages of rounding, blebbing, vacuolization, and disruption were observed as cultures aged. The dimensions of the cells were as follows: length, 0.6 to 0.7 pm; width, 0.3 to 0.4 pm at the broadest part and 0.06 to 0.08 Fm at the tip. The tip was often slightly broadened or truncate. A characteristic feature was a prominent outer layer or nap extending distally from the tip for only approximately 40 to 60% of the cell length. In negatively stained preparations, the nap appeared to be discrete 78-nm irregular particles or aggregates (Fig. 1A and D through F) , but in sections we observed a continuous finer particulate or fibrillar layer, 8 to 12 nm thick, which extended outward from the characteristic single limiting membrane of the cell (Fig. 1B and C) . In negatively stained preparations of naturally or sonically disrupted organisms (Fig. 1 D through  F) or in sections (Fig. 1C ) of some organisms (most were uniformly densely stained), we observed a fibrillar rodlike structure or terminal organelle which was approximately 210 to 250 nm long and from 35 to 60 nm wide. The proximal end of this structure was surmounted by a slightly wider cap (67 to 80 nm) (Fig. 1B  through F) . The ultrastructure of the mycoplasma, whether unfixed, glutaraldehyde fixed, negatively stained, or fixed and sectioned or whether from broth cultures or from infected cell cultures was the same.
Cultural properties. Cloned and culture-adapted strains G-37T and M-30 grown in SP-4 broth medium in glass tubes or vials produced a slightly granular turbidity and a lowering of the pH of the medium after about 4 to 5 days at 37°C. When the broth was removed from the tube or vial, a ring of material adherent to the glass was apparent, suggesting that the cells could attach to this surface. Inoculation of the mycoplasmas into T-25 plastic flasks containing 10 ml of SP-4 broth medium, followed by incubation at 37°C in a horizontal position, resulted in a similar change in the pH of the medium and a sheet of attached mycoplasma cells on the surface of the plastic after 5 days ( Fig. 2A) . Similar but less marked growth occurred at 30°C (30). The two mycoplasma strains also grew well, at least after adaptation to the SP-4 medium, in conventional mycoplasma broth medium containing 20% FBS. However, attachment to plastic or glass surfaces occurred only with strain G-37T when the organisms were grown in FBS medium. When conventional mycoplasma medium supplemented with 20% horse serum was used, strain G-37T grew only in suspension and did not attach to the surfaces of the T-25 plastic flasks. Strain M-30 did not grow or attach to surfaces when it was cultured in the medium containing horse serum. Because few colonies of strain G-37T or M-30 were apparent when those organisms were grown on SP-4 solid medium supplemented with 0.8% Noble agar, a more highly purified agar preparation (0.6% agarose) was used. On this medium, both strains produced colonies, which varied in diameter from 20 to 200 pm. Although a few colonies had a "friedegg" appearance, most colonies appeared to grow into the agarose and exhibited little surface growth (Fig. 2B) . More successful colony development occurred on SP-4 agarose medium incubated at 37°C in the GasPak system for 14 days.
The inhibitory effects of different concentrations of thallium acetate are shown in Table 2 . The concentrations of thallium used in most mycoplasma media to suppress bacterial growth (1:2,000 to 1:3,000) inhibited the growth of strain G-37T in SP-4 broth medium. A concentration of thallium acetate of 1 :4,000 was partially inhibitory, and only when a dilution of 1:5,000 was used was the growth of strain G-37'r comparable to the growth in SP-4 medium without thallium. The effects of polymyxin B on the growth of strain G-37T in SP-4 broth medium indicated that a concentration of 500 U/ml was not inhibitory ( Table 2 ), suggesting that this compound might be a suitable replacement for thallium acetate in suppressing contamination by gram-negative bacteria in clinical specimens cultured in SP-4 broth medium.
Reversion studies. Cultures of strain G-37T maintained in antibiotic-free SP-4 broth medium for five to eight consecutive passages exhibited growth characteristics similar to those observed when penicillin was present. No evidence of a change to bacterial forms was apparent when the antibiotic-free broth cultures were inoculated onto blood agar or when Gram-stained cells were examined microscopically.
Filtration studies. A cloned broth culture of strain G-37= contained lo8 CCU/ml before filtration through a series of membrane filters having 33, 1983 MYCOPLASMA GENITALIUM SP. NOV. 393 graded pore diameters. After passage through membrane filters having average pore diameters of 450, 300, 220, and 100 nm, the filtrates contained lo5, lo4, lo2, and 0 CCU/ml, respectively.
Biochemical and biological properties. The results of various biochemical tests performed on the two mycoplasma strains and other biological properties determined in this study were as follows: fermentation of glucose, positive; hydrolysis of arginine, negative; hydrolysis of urea, negative; phosphatase production, negative; tetrazolium reduction (aerobic), weak; tetrazolium reduction (anaerobic), positive; liquefaction of coagulated serum, negative; film and spot reaction, negative; susceptible to 1.5% digitonin (diameter of inhibition zone, 7 mm); hemadsorption (guinea pig or human type 0 erythrocytes), positive; sterol required for growth; culture turbidity, granular; adherent to glass and plastic surfaces; cytopathic to tissue culture cells (Vero monkey); colonies on agarose variable in size, most without a central zone; preferred atmosphere in broth, aerobic; preferred atmosphere on agar, anaerobic; preferred temperature, 37°C. The most notable characteristics were fermentation of glucose and the strong adsorption of erythrocytes (guinea pig or human type 0) to colonies of strains G-37T and M-30. Treatment of erythrocytes (human type 0) with purified neuraminidase completely abolished adsorption of these cells to colonies of strain G-37T.
Sterol requirement. The growth responses of strain G-37* to cholesterol and to FBS added to serum-free base medium are shown in Table 3 .
No significant growth was apparent in the base medium alone or when cholesterol supplements (1 to 20 kg/ml) were added to the base medium. However, there was increased multiplication when 15 to 20% FBS was incorproated into the base medium.
Serological studies. Growth inhibition and epiimmunofluorescence tests with antisera or conjugates prepared to the mycoplasmas listed in Table 1 indicated that strains G-37T and M-30 were serologically unrelated to mycoplasmas described previously, including both fermentative and nonfermentative Mycoplasma and Acholeplasma species.
Deoxyribonucleic acid. The guanine-plus-cytosine content of deoxyribonucleic acid obtained from strain G-37T was 32.4 5 1.0 mol%.
Tissue culture studies. Infection of Vero monkey kidney cell monolayers with the mycoplasmas resulted in the appearance of foci of vacuolization and cell lysis after 5 days at 37"C, as observed by optical microscopy. An examination of sections by electron microscopy verified the cytopathogenic changes and showed that there were numerous mycoplasmas closely associated with both intact and disrupting cells (Fig.  3) . Adherence of the mycoplasmas to the host cell membranes appeared to be mediated only by the nap on the tip and anterior (proximal) twothirds of the cells (Fig. 1B and C) . A similar role of the nap was observed in sections of the mycoplasmas adhering to erythrocytes (data not shown).
DISCUSSION
A preliminary analysis of some of the morphological, biological , and serological characteristics of the two new genital tract mycoplasma strains has been presented previously (27, 30) . The most unusual characteristics of this orgaNo. Of (CCU'rnl) nism are its differentiated terminal structure and strain G-37~I at 37°C for:
its ability to attach to tissue cells and to erythrocytes, apparently by the restricted nap on this structure.
14 Days 21 Days The morphology and ultrastructure of the new mycoplasma resemble most closely the morphology and ultrastructure of M . pneumoniae (3, 32) , although Mycoplasma gallisepticum (l), Mycoplusmu alvi (14), and Mycoplasma sualvi (15) are also flask shaped and possess terminal organelles of some sort. Two of these species ( M . pneumoniae and M . gallisepticum) are pathogenic and are known to attach to glass (22, 25), to hemadsorb (19,20) , and to cytadsorb (24, (32) (33) (34) ; however, unlike the apparently nonpathogenic species M . alvi and M . sualvi, M . pneumoniae and M . gallisepticum have not been found in the urogenital tracts of their hosts. A surface nap has been observed on M . gallisepticum (7), but apparently this nap is not restricted INT. J. SYST. BACTERIOL. to the terminal bleb, which is said to mediate cytadsorption (24, 33) . No surface layers have been defined on M . alvi and M . sualvi, and the status of hemadsorption and cytadsorption for these two species is unknown. When originally reported (27, 30), the new mycoplasma was the first example of a structurally differentiated mycoplasma that adheres to cells by a clearly defined nap restricted to its terminal region. After this original report, a similar but more restricted terminal nap was observed on M . pneumoniae, and this nap has been shown by labeling with monoclonal antibody (16) to include or consist of P1, a trypsin-sensitive surface protein responsible for the previously observed (32) terminus-mediated cytabsorption of this mycoplasma. The nature of the nap of the new genital mycoplasma has not been determined yet.
The recovery of the organisms from human genital tracts is not proof that this site represents the primary habitat of this mycoplasma. Further attempts to isolate the organism from other anatomical sites in humans by using the methods described previously (30) will be necessary to define the true habitat. However, the mycoplasmas recovered from two patients with NGU are important additions to the mycoplasma flora of the human urogenital tract, Although the data presented here and elsewhere (30) suggest that SP-4 medium is a crucial factor in recovery of the organisms, the clear demonstration of the inhibitory activity of thallium acetate (a component frequently utilized in mycoplasma media to suppress growth of urogenital tract and oral cavity bacteria) indicates that the absence of thallium in the SP-4 medium used for primary isolation was an important factor. There are not enough data to relate this microorganism to NGU or to other urogenital infections, but its presence in urethras, its isolation on special media, its specialized structure, and its capacity to adhere to cells and produce cytopathic effects suggest that it may have a role in human disease. Efforts to define the distribution of this mycoplasma and to clarify its role in human disease are in progress.
Our evaluation of the properties of the microorganisms described above fulfills the essential criteria for mycoplasmas, including absence of cell walls, filterability, lack of reversion to bacteria with cell walls when grown in antibioticfree medium, penicillin resistance, and production of typical colonies on agarose. The two strains which we studied are serologically distinct from other members of species, subspecies, or unclassified serotypes of the order Mycoplasmatales. The growth requirement of these strains for sterol and their morphology place these microorganisms in the family Mycoplasmataceae. An inability to hydrolyze urea indicates that the organism should be assigned to the genus Mycoplasma. We believe that this microorganism represents a new species within this genus and, therefore, propose the name Mycoplasma genitalium (ge. ni. ta' lium. L. n. genitalis genitals; genitalium pertaining to the genitals). Strain G-37 is the type strain. A cloned line of this strain has been deposited in the American Type Culture Collection as strain ATCC 3353OT.
